Financial Health Assessment — HEBITEL LTD (07824186)

Patient profile: Private limited company, incorporated October 2011, management consultancy (SIC 70229) with a stated focus on telecom brand/MVNO management. One employee. Micro-scale balance sheet. Accounts to 31 October 2025 filed under the small companies regime (filleted — no profit and loss account on public record). No overdue filings, no insolvency events, no director disqualification records.

Important caveat before we begin: this assessment is a diagnostic reading of the publicly filed accounts only. Because the company files filleted accounts, revenue, gross margin and operating costs are not disclosed. That is itself a clinical finding — see below.

1. Financial Health Score

Grade: D — Frail but currently stable; chronically thin reserves with acute warning signs

Why D and not F: the company is alive, compliant, and has its strongest cash position in a decade. Why not C: the improvement in cash appears substantially funded by an unpaid tax bill rather than by trading, and the balance sheet has produced essentially no durable wealth in fourteen years.

2. Key Vital Signs

The pulse: net assets (shareholders' funds)

This is the most revealing line in the whole file. Over ten years the company has never built a meaningful equity base. It has hovered at £1, dipped into negative territory twice, and finished 2025 at £161. In medical terms: a heartbeat that is present but barely registering — the patient is alive, but has not gained weight in a decade.

The circulation: cash at bank

Cash flow is arrhythmic — it surges and collapses with no steady rhythm. A business with predictable trading produces a relatively smooth cash line. This pattern is characteristic of lumpy, project-by-project income with no recurring revenue base, and no cash buffer discipline.

The blood pressure: liquidity

This is the critical adjustment. A loan to the director is not a liquid asset — it will not convert to cash through normal trading. Strip it out and the company's working capital is negative £5,517. The healthy-looking 1.01 ratio is, in part, an optical illusion.

The blood count: what the "debtors" actually are

There are no trade debtors at all — not in 2025, and only £167 of director's loan in 2024. Either the company collects instantly (excellent discipline, unusual) or genuine trading activity is very small. Either way, 65% of the debtor book is money owed by the director, not by customers.

The infection markers: creditors

This is the single most important finding in the file. Cash rose by £10,087 while the tax and social security creditor rose by £14,660. The correlation is too strong to ignore: the apparent cash strength is substantially funded by tax collected or accrued but not yet paid. That is not a healthy cash flow — it is a temporary loan from HMRC, and it will be called in.

Other vitals

• Fixed assets: £0. Plant and machinery cost £3,702, fully depreciated. Asset-light — good for flexibility, bad for borrowing capacity (no collateral).
• Share capital: £1–£2. The equity cushion is nominal. Almost all funding comes from creditors.
• Employees: 1. Maximum key-person concentration.
• Related-party exposure: director's loan rose from £167 to £5,678 (+£5,511) — cash leaving the company to its director at the same time as a tax liability was building.

3. Diagnosis

Primary condition: Chronic under-capitalisation with an acute tax-funding dependency

Symptom 1 — The "borrowed vitality" of the 2025 cash position. The patient looks better this year: cash £10,087 versus nil, positive net assets versus a deficit. But the improvement is not earned — it is financed. £14,943 is owed to HMRC, of which the overwhelming majority is new this year. If that liability were settled tomorrow, cash would fall to roughly −£4,856. The company's vitality is being rented, not generated.

Symptom 2 — Negative adjusted working capital. Excluding the director's loan, current liabilities exceed current assets by £5,517. In plain terms: if every short-term asset were converted at face value and every short-term creditor called, the company could not pay — before considering that one "asset" is a receivable from its own director.

Symptom 3 — Fourteen years, £160 of retained profit. This is the deepest diagnosis. A consultancy with one employee and negligible capital requirements should, if it is trading profitably, accumulate reserves. It has not. Either margins are wafer-thin, income is intermittent, or profits are being extracted rather than retained. The rising director's loan points toward the third explanation.

Symptom 4 — Related-party lending with tax consequences. The presence of both an S455 debtor (£3,055) and an S455 creditor (£2,457) shows the company is already inside the s455 regime for loans to participators. Under UK tax rules, a loan to a participator that is not repaid within nine months of the year end triggers a tax charge (currently 33.75% of the loan). The £5,678 balance implies a potential charge in the region of £1,900 if it remains outstanding past 31 July 2026. There are also potential benefit-in-kind implications for the director, and — importantly — a distribution-law question: a company with £160 of distributable reserves cannot readily justify extracting value as a loan if it may never be repayable.

Symptom 5 — No trade debtor book. Zero trade debtors at both year ends is unusual for a consultancy. Combined with a single employee and a £2 share capital, it suggests a very small operating footprint — possibly a vehicle for the principal's consultancy income rather than a scaled trading business. That is not inherently wrong, but it means the "business" and the "individual" are not separable, and there is no enterprise value independent of the director.

Symptom 6 — Total dependence on one person. One employee, one director, two PSCs each holding 25–50%. There is no redundancy in the system. Illness, disagreement between the two controlling parties, or loss of a single client would be an immediate systemic shock.

What is healthy

To be fair to the patient, several readings are genuinely good: - Compliance is impeccable — no overdue accounts or confirmation statements, no insolvency history, no disqualification records. - No bank debt. The overdraft has been cleared. There is no lender pressure. - Asset-light model — minimal fixed costs, no leasehold or equipment burden, high flexibility. - Cash is at a ten-year high, whatever its provenance. - The company has survived fourteen years, including the 2020–21 disruption, without failing. Resilience is a real asset.

4. Prognosis

Base case (most likely): continued stable frailty. The company continues as a small, compliant, low-surplus vehicle. Cash oscillates; reserves stay near zero; the director's loan is repaid and re-drawn. No crisis, but no wealth creation either. Outlook: stable but stagnant.

Adverse case: liquidity event within 12–18 months. If HMRC pursues the £14,943 (particularly if it includes overdue PAYE/VAT rather than a corporation tax provision), and the director's loan is not repaid, the company faces a combined cash demand of roughly £16,800 against £10,087 of cash. That is a £6,700+ shortfall with no fixed assets to borrow against and no reserves to absorb it. At that point the balance sheet tips negative and the director must consider whether continued trading is prudent — the territory of wrongful trading risk. Outlook: distress.

Favourable case: recapitalisation. Repay the director's loan, settle or schedule the tax, retain profits for two to three years, and the company could move to a C grade with genuine positive working capital. The underlying model is low-cost and flexible enough to support this. Outlook: recoverable with discipline.

Key prognostic indicator to watch: the tax and social security creditor at the next year end. If it falls materially and cash holds, the patient is genuinely recovering. If it rises again alongside cash, the dependency is deepening.

5. Recommendations — the treatment plan

Immediate (0–3 months)

1. Diagnose the £14,943. Establish precisely what it comprises — VAT, PAYE/NIC, or corporation tax. PAYE/VAT arrears mean trading stress; corporation tax means profit. The treatment is completely different. If any element is overdue, contact HMRC proactively and request a Time to Pay arrangement before enforcement. HMRC is materially more cooperative with early, voluntary engagement.
2. Put the director's loan on a formal repayment schedule. The nine-month window after 31 October 2025 closes around 31 July 2026. Repayment by then avoids the s455 charge entirely. Document the loan, the interest terms (or the beneficial loan / benefit-in-kind position), and the repayment plan in board minutes.
3. Confirm distributable reserves before any further extraction. With £160 of retained profit, there is essentially no capacity for lawful dividends. Any further value taken out must be salary (taxed through payroll) or a properly documented, repayable loan.
4. Build a 13-week cash flow forecast. Weekly, not monthly. Given cash volatility of this magnitude, weekly visibility is the minimum safe monitoring frequency.

Short term (3–12 months)

5. Produce monthly management accounts — including a P&L. The company currently files filleted accounts with no profit and loss account. From a diagnostic standpoint, the business is being run without a view of its own vital signs. Track revenue, gross margin, operating costs and cash conversion monthly.
6. Set a cash buffer target of three months' operating costs, held separately from tax money. Critically: ring-fence tax collected — treat VAT and PAYE as money that is never the company's. This single discipline would have prevented the current position.
7. Reduce related-party concentration. Target zero director's loan by the next year end. This removes the s455 exposure, the benefit-in-kind question, and the distribution-law risk in one move.

Medium term (12 months+)

8. Rebuild equity deliberately. Aim to retain enough profit to lift shareholders' funds to at least 10% of total assets (currently 0.9%). This is the difference between a business that can absorb a shock and one that cannot.
9. Diversify the debtor and client base. With no trade debtors, customer concentration is unknown but likely high. Two or three anchor clients with retainer-style contracts would smooth the arrhythmic cash pattern.
10. Address key-person risk. Document processes, consider key-person insurance, and clarify the relationship between the two 25–50% PSCs in a shareholders' agreement — including what happens on death, disagreement or exit.
11. Review the structure. If the activity is genuinely the principal's consultancy income, consider whether a limited company remains the most efficient and least administratively burdensome vehicle. If it is intended to be a scalable MVNO/telecom advisory business, it needs a growth plan with revenue targets — the current balance sheet shows no evidence of scale.